Insulin Delivery Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The report covers Global Insulin Delivery Devices Market Share and it is segmented by Type (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, Jet Injectors), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and Latin America). The market values are provided in terms of (USD million) for the above segments.

Insulin Delivery Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Insulin Delivery Devices Market Size

Insulin Delivery Devices Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Market Size (2025) USD 40.98 Billion
Market Size (2030) USD 48.84 Billion
CAGR (2025 - 2030) 3.57 %
Fastest Growing Market North America
Largest Market Asia Pacific

Major Players

Insulin Delivery Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Insulin Delivery Devices Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Insulin Delivery Devices Market Analysis

The Insulin Delivery Devices Market size is estimated at USD 40.98 billion in 2025, and is expected to reach USD 48.84 billion by 2030, at a CAGR of 3.57% during the forecast period (2025-2030).

The COVID-19 pandemic substantially impacted the insulin delivery devices market. Type-1 diabetes patients are impacted more during COVID-19. People with diabetes have a weak immune system; hence, with COVID-19, the immune system gets weaker fast. People with diabetes may have more chances of serious complications than normal people. The manufacturers of insulin delivery devices have taken care during COVID-19 to deliver insulin delivery devices to diabetes patients with the help of local governments. NovoNordisk stated on their website that 'Since the start of COVID-19, our commitment to patients, our employees, and the communities where we operate has remained unchanged, we continue to supply our medicines and devices to people living with diabetes and other serious chronic diseases, safeguard the health of our employees, and take actions to support doctors and nurses as they work to defeat COVID-19.' Doctors globally suggest diabetes patients check their diabetes levels more often to be careful. The intake of medicine has increased, leading to an increased usage of insulin delivery devices.

According to International Diabetes Federation (IDF), the adult diabetes population in 2021 was approximately 537 million, and this number is expected to increase by 643 million in 2030. Approximately 10% of the total diabetes population has Type-1 diabetes, and of this 10% of people, only 80-90% use insulin delivery devices; however, the usage of insulin is rising from time to time, and even Type-2 diabetes patients are using the insulin delivery devices during COVID-19.

Technological advancements in insulin delivery devices have increased over time for safer and more accurate insulin administration. Therefore, owing to the factors mentioned above, the studied market is anticipated to witness growth over the analysis period.

Insulin Delivery Devices Industry Overview

The insulin delivery devices market is consolidated due to only a few major companies operating globally and regionally. The competitive landscape includes an analysis of a few international and local companies that hold market shares and are well known, including Novo Nordisk, Sanofi, Eli Lily and Company, Medtronic, Insulet, Ypsomped, Becton, Dickinson and Company, among others.

Insulin Delivery Devices Market Leaders

  1. Novo Nordisk

  2. Medtronic

  3. Sanofi

  4. Ypsomed

  5. Eli Lilly and Company

  6. *Disclaimer: Major Players sorted in no particular order
Insulin Delivery Devices Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Insulin Delivery Devices Market News

  • In March 2022, Novo Nordisk announced that two smart connected insulin pens, NovoPen 6 and NovoPen Echo Plus, were available on prescription for people with diabetes treated with Novo Nordisk insulin in the United Kingdom.
  • In January 2022, Boston-based Insulet Corp. announced that the FDA (Food and Drug Administration) cleared the new Omnipod 5 system, marking the company's entry into the automated insulin delivery (AID) universe.

Insulin Delivery Devices Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
  • 4.3 Market Restraints
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Intensity of Competitive Rivalry

5. Market Segmentation

  • 5.1 By Management Devices
    • 5.1.1 Insulin Pump
    • 5.1.1.1 Insulin Pump Devices (Value and Volume, 2016 - 2027)
    • 5.1.1.2 Insulin Pump Reservoirs (Value and Volume, 2016 - 2027)
    • 5.1.1.3 Infusion Sets (Value and Volume, 2016 - 2027)
    • 5.1.2 Insulin Syringes (Value and Volume, 2016 - 2027)
    • 5.1.3 Cartridges in reusable pens (Value and Volume, 2016 - 2027)
    • 5.1.4 Disposable Pens (Value and Volume, 2016 - 2027)
    • 5.1.5 Jet Injectors (Value and Volume, 2016 - 2027)
  • 5.2 Geography
    • 5.2.1 North America
    • 5.2.1.1 United States (Value and Volume, 2016 - 2027)
    • 5.2.1.1.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
    • 5.2.1.2 Canada (Value and Volume, 2016 - 2027)
    • 5.2.1.2.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
    • 5.2.1.3 Rest of North America (Value and Volume, 2016 - 2027)
    • 5.2.1.3.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
    • 5.2.2 Europe
    • 5.2.2.1 France (Value and Volume, 2016 - 2027)
    • 5.2.2.1.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
    • 5.2.2.2 Germany (Value and Volume, 2016 - 2027)
    • 5.2.2.2.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
    • 5.2.2.3 Italy (Value and Volume, 2016 - 2027)
    • 5.2.2.3.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
    • 5.2.2.4 Spain (Value and Volume, 2016 - 2027)
    • 5.2.2.4.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
    • 5.2.2.5 United Kingdom (Value and Volume, 2016 - 2027)
    • 5.2.2.5.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
    • 5.2.2.6 Russia (Value and Volume, 2016 - 2027)
    • 5.2.2.6.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
    • 5.2.2.7 Rest of Europe (Value and Volume, 2016 - 2027)
    • 5.2.2.7.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
    • 5.2.3 Latin America
    • 5.2.3.1 Mexico (Value and Volume, 2016 - 2027)
    • 5.2.3.1.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
    • 5.2.3.2 Brazil (Value and Volume, 2016 - 2027)
    • 5.2.3.2.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
    • 5.2.3.3 Rest of Latin America (Value and Volume, 2016 - 2027)
    • 5.2.3.3.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
    • 5.2.4 Asia-Pacific
    • 5.2.4.1 Japan (Value and Volume, 2016 - 2027)
    • 5.2.4.1.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
    • 5.2.4.2 South Korea (Value and Volume, 2016 - 2027)
    • 5.2.4.2.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
    • 5.2.4.3 China (Value and Volume, 2016 - 2027)
    • 5.2.4.3.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
    • 5.2.4.4 India (Value and Volume, 2016 - 2027)
    • 5.2.4.4.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
    • 5.2.4.5 Australia (Value and Volume, 2016 - 2027)
    • 5.2.4.5.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
    • 5.2.4.6 Vietnam (Value and Volume, 2016 - 2027)
    • 5.2.4.6.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
    • 5.2.4.7 Malaysia (Value and Volume, 2016 - 2027)
    • 5.2.4.7.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
    • 5.2.4.8 Indonesia (Value and Volume, 2016 - 2027)
    • 5.2.4.8.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
    • 5.2.4.9 Philippines (Value and Volume, 2016 - 2027)
    • 5.2.4.9.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
    • 5.2.4.10 Thailand (Value and Volume, 2016 - 2027)
    • 5.2.4.10.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
    • 5.2.4.11 Rest of Asia-Pacific (Value and Volume, 2016 - 2027)
    • 5.2.4.11.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
    • 5.2.5 Middle-East and Africa
    • 5.2.5.1 Saudi Arabia (Value and Volume, 2016 - 2027)
    • 5.2.5.1.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
    • 5.2.5.2 Iran (Value and Volume, 2016 - 2027)
    • 5.2.5.2.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
    • 5.2.5.3 Egypt (Value and Volume, 2016 - 2027)
    • 5.2.5.3.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
    • 5.2.5.4 Oman (Value and Volume, 2016 - 2027)
    • 5.2.5.4.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
    • 5.2.5.5 South Africa (Value and Volume, 2016 - 2027)
    • 5.2.5.5.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
    • 5.2.5.6 Rest of Middle-East and Africa (Value and Volume, 2016 - 2027)
    • 5.2.5.6.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

6. MARKET INDICATORS

  • 6.1 Type-1 Diabetes population (2016 - 2027)
  • 6.2 Type-2 Diabetes population (2016 - 2027)

7. COMPETITIVE LANDSCAPE

  • 7.1 Company profiles
    • 7.1.1 Novo Nordisk AS
    • 7.1.2 Sanofi SA
    • 7.1.3 Eli Lilly and Company
    • 7.1.4 Medtronic PLC
    • 7.1.5 Insulet corporation
    • 7.1.6 Ypsomed
    • 7.1.7 Becton, Dickinson and Company
  • *List Not Exhaustive
  • 7.2 Company Share Analysis
    • 7.2.1 Novo Nordisk AS
    • 7.2.2 Sanofi SA
    • 7.2.3 Eli Lilly and Company
    • 7.2.4 Others

8. MARKET OPPORTUNITIES AND FUTURE TRENDS

You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Insulin Delivery Devices Industry Segmentation

The insulin delivery devices market is expected to register a CAGR greater than 3% over the forecast period. The insulin delivery devices market is segmented by type (insulin pumps, insulin syringes, cartridges in reusable pens, disposable pens, jet injectors) and geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and Latin America). The report offers the value (in USD million) for the above segments. The report also covers the estimated market sizes and trends for 25 countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Management Devices Insulin Pump Insulin Pump Devices (Value and Volume, 2016 - 2027)
Insulin Pump Reservoirs (Value and Volume, 2016 - 2027)
Infusion Sets (Value and Volume, 2016 - 2027)
Insulin Syringes (Value and Volume, 2016 - 2027)
Cartridges in reusable pens (Value and Volume, 2016 - 2027)
Disposable Pens (Value and Volume, 2016 - 2027)
Jet Injectors (Value and Volume, 2016 - 2027)
Geography North America United States (Value and Volume, 2016 - 2027) By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Canada (Value and Volume, 2016 - 2027) By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Rest of North America (Value and Volume, 2016 - 2027) By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Europe France (Value and Volume, 2016 - 2027) By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Germany (Value and Volume, 2016 - 2027) By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Italy (Value and Volume, 2016 - 2027) By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Spain (Value and Volume, 2016 - 2027) By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
United Kingdom (Value and Volume, 2016 - 2027) By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Russia (Value and Volume, 2016 - 2027) By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Rest of Europe (Value and Volume, 2016 - 2027) By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Latin America Mexico (Value and Volume, 2016 - 2027) By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Brazil (Value and Volume, 2016 - 2027) By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Rest of Latin America (Value and Volume, 2016 - 2027) By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Asia-Pacific Japan (Value and Volume, 2016 - 2027) By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
South Korea (Value and Volume, 2016 - 2027) By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
China (Value and Volume, 2016 - 2027) By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
India (Value and Volume, 2016 - 2027) By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Australia (Value and Volume, 2016 - 2027) By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Vietnam (Value and Volume, 2016 - 2027) By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Malaysia (Value and Volume, 2016 - 2027) By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Indonesia (Value and Volume, 2016 - 2027) By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Philippines (Value and Volume, 2016 - 2027) By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Thailand (Value and Volume, 2016 - 2027) By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Rest of Asia-Pacific (Value and Volume, 2016 - 2027) By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Middle-East and Africa Saudi Arabia (Value and Volume, 2016 - 2027) By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Iran (Value and Volume, 2016 - 2027) By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Egypt (Value and Volume, 2016 - 2027) By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Oman (Value and Volume, 2016 - 2027) By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
South Africa (Value and Volume, 2016 - 2027) By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Rest of Middle-East and Africa (Value and Volume, 2016 - 2027) By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Need A Different Region or Segment?
Customize Now

Insulin Delivery Devices Market Research FAQs

How big is the Insulin Delivery Devices Market?

The Insulin Delivery Devices Market size is expected to reach USD 40.98 billion in 2025 and grow at a CAGR of 3.57% to reach USD 48.84 billion by 2030.

What is the current Insulin Delivery Devices Market size?

In 2025, the Insulin Delivery Devices Market size is expected to reach USD 40.98 billion.

Who are the key players in Insulin Delivery Devices Market?

Novo Nordisk, Medtronic, Sanofi, Ypsomed and Eli Lilly and Company are the major companies operating in the Insulin Delivery Devices Market.

Which is the fastest growing region in Insulin Delivery Devices Market?

North America is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Insulin Delivery Devices Market?

In 2025, the Asia Pacific accounts for the largest market share in Insulin Delivery Devices Market.

What years does this Insulin Delivery Devices Market cover, and what was the market size in 2024?

In 2024, the Insulin Delivery Devices Market size was estimated at USD 39.52 billion. The report covers the Insulin Delivery Devices Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Insulin Delivery Devices Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Insulin Pumps Industry Report

Statistics for the 2025 Insulin Delivery Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Insulin Delivery Devices analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.